Cosmo Pharmaceuticals N.V.
CMOPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $50 | $186 | $199 |
| Short-Term Investments | $99 | $0 | $55 | $24 |
| Receivables | $19 | $28 | $39 | $24 |
| Inventory | $14 | $14 | $11 | $13 |
| Other Curr. Assets | $27 | $9 | $15 | $16 |
| Total Curr. Assets | $202 | $102 | $306 | $276 |
| Property Plant & Equip (Net) | $29 | $29 | $30 | $30 |
| Goodwill | $24 | $24 | $24 | $24 |
| Intangibles | $332 | $356 | $367 | $373 |
| Long-Term Investments | -$67 | $3 | -$47 | $25 |
| Tax Assets | $19 | $0 | $15 | $19 |
| Other NC Assets | $108 | $40 | $65 | $58 |
| Total NC Assets | $445 | $452 | $453 | $530 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $647 | $554 | $760 | $806 |
| Liabilities | – | – | – | – |
| Payables | $9 | $9 | $8 | $4 |
| Short-Term Debt | $1 | $1 | $172 | $1 |
| Tax Payable | $21 | $3 | $3 | $4 |
| Deferred Revenue | $0 | $9 | $0 | $6 |
| Other Curr. Liab. | $18 | $4 | $16 | $7 |
| Total Curr. Liab. | $48 | $26 | $195 | $21 |
| LT Debt | $1 | $1 | $2 | $169 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $91 | $95 | $97 | $100 |
| Other NC Liab. | $1 | $4 | $2 | $3 |
| Total NC Liab. | $93 | $99 | $101 | $272 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $2 | $3 |
| Total Liabilities | $142 | $125 | $296 | $293 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $11 | $18 |
| Common Stock | $5 | $5 | $5 | $5 |
| Retained Earnings | $323 | $297 | $255 | $293 |
| AOCI | $0 | -$21 | -$11 | -$18 |
| Other Equity | $171 | $142 | $198 | $207 |
| Total Equity | $498 | $422 | $457 | $505 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $7 | $7 | $7 | $7 |
| Total Liab. & Tot. Equity | $647 | $554 | $760 | $806 |
| Net Debt | -$42 | -$48 | -$12 | -$29 |